What is IOVA's current stock price?

As of now, IOVA is trading at $5.78, with a daily change of +3.03%.

What are IOVA stock strengths?

IOVA strengths include Earnings are forecast to grow, Trading below its fair value, .

What are the risks associated with IOVA stock?

IOVA Key risk is its Low Risk Level, .

What is IOVA next earnings date?

IOVA next earnings report is scheduled for Feb 26, 2025.

What is IOVA's current stock rating?

IOVA's current stock rating is Hold.

Should I buy IOVA stock right now?

Based on the current rating of Hold, it is advisable to consider Hold as your next step with IOVA stock.

Is IOVA a Strong Buy right now?

IOVA's current stock rating is Hold, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for IOVA?

A 'Strong Buy' rating for IOVA indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for IOVA?

A 'Strong Sell' rating for IOVA suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence IOVA's stock rating?

IOVA's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Iovance Biotherapeutics (IOVA) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

IOVA

Iovance Biotherapeutics

$5.78

+$0.17 | +3.03%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Open

$ 5.69

MKT CAP

$ 1.76B

High

$ 6.09

VOL

$ 10.87M

Low

$ 5.68

AVG VOL

$ 8.61M

Chart

6.4

8.55

9.74

16.49

1year

6month

3month

1month

IOVA Latest Headlines +

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4). SAN CARLOS Calif. Feb. 21 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics Inc. (NASDAQ: IOVA) (Iovance or the Company) a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer today announced that on February 21 2025 (the Date of Grant) the Company approved the grant of inducement stock options covering an

Today

Activity

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know. Iovance Biotherapeutics (IOVA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Feb 20, 2025

Earnings

Iovance Biotherapeutics Grants Inducement Stock Options and Restricted Stock Units to New Chief Commercial Officer. Iovance Biotherapeutics grants stock options and restricted units to new Chief Commercial Officer Daniel Kirby totaling 305000 shares.

Wed Feb 12, 2025

Activity

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4). SAN CARLOS Calif. Feb. 12 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics Inc. (NASDAQ: IOVA) (Iovance or the Company) a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer today announced that on February 10 2025 (the Date of Grant) the Company approved the grant of inducement stock options and restrict

Wed Feb 12, 2025

Activity

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer. SAN CARLOS Calif. Feb. 10 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics Inc. (NASDAQ: IOVA) a commercial biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer today announced that Dan Kirby will join the Companys executive leadership team in the newly created role of Chief Commercial Officer effective today.

Mon Feb 10, 2025

Activity

Explore our IOVA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored IOVA Stock Strategies
Effective Risk Management

FIND US ON

Receive our IOVA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

IOVA

Iovance Biotherapeutics

$5.78

+$0.17 | +3.03%

Chart

6.4

8.55

9.74

16.49

1year

6month

3month

1month

Discover IOVA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of IOVA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our IOVA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

IOVA Stock trends

IOVA Stock performance

IOVA Stock analysis

IOVA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

IOVA Stock Analysis for the Last 90 Days

IOVA Risk Level

IOVA Analysts Opinion

IOVA Street Consensus

IOVA Performance Sentiment

Technical Price Levels

IOVA Financial Health

Explore our IOVA Stock insights

Receive our IOVA Daily Alerts

IOVA Stock Analysis for the Last 90 Days

IOVA Street Consensus

Technical Price Levels

Discover IOVA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of IOVA. We're here to help you make informed investment decisions today.

Receive our IOVA Daily Alerts